These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Targets of vitamin D receptor signaling in the mammary gland. Welsh J J Bone Miner Res; 2007 Dec; 22 Suppl 2():V86-90. PubMed ID: 18290729 [TBL] [Abstract][Full Text] [Related]
6. Breast cancer cell regulation by high-dose Vitamin D compounds in the absence of nuclear vitamin D receptor. Valrance ME; Welsh J J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):221-5. PubMed ID: 15225775 [TBL] [Abstract][Full Text] [Related]
8. 1alpha,25-Dihydroxyvitamin D(3) antiproliferative actions involve vitamin D receptor-mediated activation of MAPK pathways and AP-1/p21(waf1) upregulation in human osteosarcoma. Wu W; Zhang X; Zanello LP Cancer Lett; 2007 Aug; 254(1):75-86. PubMed ID: 17412493 [TBL] [Abstract][Full Text] [Related]
9. Resveratrol potentiates vitamin D and nuclear receptor signaling. Dampf Stone A; Batie SF; Sabir MS; Jacobs ET; Lee JH; Whitfield GK; Haussler MR; Jurutka PW J Cell Biochem; 2015 Jun; 116(6):1130-43. PubMed ID: 25536521 [TBL] [Abstract][Full Text] [Related]
10. Dissociation of growth arrest and CYP24 induction by VDR ligands in mammary tumor cells. Valrance ME; Brunet AH; Acosta A; Welsh J J Cell Biochem; 2007 Aug; 101(6):1505-19. PubMed ID: 17286279 [TBL] [Abstract][Full Text] [Related]
11. Transcriptomic Response to 1,25-Dihydroxyvitamin D in Human Fibroblasts with or without a Functional Vitamin D Receptor (VDR): Novel Target Genes and Insights into VDR Basal Transcriptional Activity. Costa PLF; França MM; Katayama ML; Carneiro ET; Martin RM; Folgueira MAK; Latronico AC; Ferraz-de-Souza B Cells; 2019 Apr; 8(4):. PubMed ID: 30959822 [TBL] [Abstract][Full Text] [Related]
12. Dynamics of 1α,25-dihydroxyvitamin D3-dependent chromatin accessibility of early vitamin D receptor target genes. Seuter S; Pehkonen P; Heikkinen S; Carlberg C Biochim Biophys Acta; 2013 Dec; 1829(12):1266-75. PubMed ID: 24185200 [TBL] [Abstract][Full Text] [Related]
13. Anti-proliferative action of vitamin D in MCF7 is still active after siRNA-VDR knock-down. Costa JL; Eijk PP; van de Wiel MA; ten Berge D; Schmitt F; Narvaez CJ; Welsh J; Ylstra B BMC Genomics; 2009 Oct; 10():499. PubMed ID: 19863778 [TBL] [Abstract][Full Text] [Related]
15. VDR in salivary gland homeostasis and cancer. DeSantis KA; Robilotto SL; Matson M; Kotb NM; Lapierre CM; Minhas Z; Leder AA; Abdul K; Facteau EM; Welsh J J Steroid Biochem Mol Biol; 2020 May; 199():105600. PubMed ID: 31958633 [TBL] [Abstract][Full Text] [Related]
16. The prostate cancer TMPRSS2:ERG fusion synergizes with the vitamin D receptor (VDR) to induce CYP24A1 expression-limiting VDR signaling. Kim JS; Roberts JM; Bingman WE; Shao L; Wang J; Ittmann MM; Weigel NL Endocrinology; 2014 Sep; 155(9):3262-73. PubMed ID: 24926821 [TBL] [Abstract][Full Text] [Related]
17. Curcumin: a novel nutritionally derived ligand of the vitamin D receptor with implications for colon cancer chemoprevention. Bartik L; Whitfield GK; Kaczmarska M; Lowmiller CL; Moffet EW; Furmick JK; Hernandez Z; Haussler CA; Haussler MR; Jurutka PW J Nutr Biochem; 2010 Dec; 21(12):1153-61. PubMed ID: 20153625 [TBL] [Abstract][Full Text] [Related]
18. Crosstalk between the peroxisome proliferator-activated receptor γ (PPARγ) and the vitamin D receptor (VDR) in human breast cancer cells: PPARγ binds to VDR and inhibits 1α,25-dihydroxyvitamin D3 mediated transactivation. Alimirah F; Peng X; Yuan L; Mehta RR; von Knethen A; Choubey D; Mehta RG Exp Cell Res; 2012 Nov; 318(19):2490-7. PubMed ID: 22884583 [TBL] [Abstract][Full Text] [Related]
19. Autocrine TGFbeta signaling mediates vitamin D3 analog-induced growth inhibition in breast cells. Yang L; Yang J; Venkateswarlu S; Ko T; Brattain MG J Cell Physiol; 2001 Sep; 188(3):383-93. PubMed ID: 11473365 [TBL] [Abstract][Full Text] [Related]
20. The vitamin D receptor is involved in the regulation of human breast cancer cell growth via a ligand-independent function in cytoplasm. Trivedi T; Zheng Y; Fournier PGJ; Murthy S; John S; Schillo S; Dunstan CR; Mohammad KS; Zhou H; Seibel MJ; Guise TA Oncotarget; 2017 Apr; 8(16):26687-26701. PubMed ID: 28460457 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]